Isabelle Hoorens, MD; Katrien Vossaert, MD; Lore Pil; et al.
free access
JAMA Dermatol. 2016;152(1):27-34. doi:10.1001/jamadermatol.2015.2680
This population-based cross-sectional study compares use, effectiveness, and cost of 2 skin cancer screening strategies鈥攖otal-body examination vs lesion-directed screening.
-
Editorial
Cost-effective Melanoma Screening
June K. Robinson, MD; Allan C. Halpern, MD
JAMA Dermatol
Young H. Lee, MD; Thomas P. Scharnitz, BS; Joshua Muscat, PhD; et al.
free access
has audio
JAMA Dermatol. 2016;152(1):35-44. doi:10.1001/jamadermatol.2015.3091
This systematic review and meta-analysis examines the need for frequent laboratory monitoring to detect adverse effects in patients receiving isotretinoin therapy for acne vulgaris.
-
Podcast:
Laboratory Monitoring During Isotretinoin Therapy for Acne (JAMA Dermatology)
Camille Hua, MD; Lise Boussemart, MD, PhD; Christine Mateus, MD; et al.
free access
JAMA Dermatol. 2016;152(1):45-51. doi:10.1001/jamadermatol.2015.2707
This observational study evaluated the appearance of vitiligo as a visible marker of tumor response in a population of patients with melanoma who received treatment with pembrolizumab.
Vassiliki Tzanetakou, MD; Theodora Kanni, MD; Sophia Giatrakou, MD; et al.
free access
JAMA Dermatol. 2016;152(1):52-59. doi:10.1001/jamadermatol.2015.3903
This randomized clinical trial investigated the safety and efficacy of the anti-inflammatory biological therapy anakinra in 20 patients with Hurley stage II or III hidradenitis suppurativa.
Christina Lam, MD; Stephanie W. Liu, MD; Henry B. Townsend, MD; et al.
free access
JAMA Dermatol. 2016;152(1):60-66. doi:10.1001/jamadermatol.2015.3088
This study reports the results of pilot testing of a questionnaire designed to determine whether patients can distinguish cutaneous lupus erythematosus from other skin disorders.
Sherry H. Yu, BS, BA; Apra Sood, MD; James S. Taylor, MD
free access
JAMA Dermatol. 2016;152(1):67-72. doi:10.1001/jamadermatol.2015.3606
This medical record review of patients undergoing patch testing with combined methylchloroisothiazolinone-methylisothiazolinone and methylisothiazolinone measures the prevalence of contact allergy.
Brandon E. Cohen, BS; Kathryn J. Martires, MD; Roger S. Ho, MD, MS, MPH
free access
JAMA Dermatol. 2016;152(1):73-79. doi:10.1001/jamadermatol.2015.3605
This study of National Health and Nutrition Examination Survey data reports that self-reported history of psoriasis was independently associated with major depression as assessed by a validated screening tool, even when controlling for comorbidities.